Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00925522 · ClinicalTrials.gov registry record · NA
Therapy Cool Path Ablate VT
A NA study, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00925522 is a NA study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 20 participants.
The verdict
NCT00925522, a NA study, was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
To demonstrate that ablation with the Therapy Cool Path Duo cardiac ablation system can eliminate ischemic VT and that its use does not result in an unacceptable risk of serious adverse events.
Interventions
- DEVICE Therapy Cool Path Duo Cardiac Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00925522
The ClinicalTrials.gov registry entry for NCT00925522 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Therapy Cool Path Duo Cardiac Ablation System is the first listed.
NCT00925522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00925522 about?
NCT00925522 is a clinical study titled "Therapy Cool Path Ablate VT". To demonstrate that ablation with the Therapy Cool Path Duo cardiac ablation system can eliminate ischemic VT and that its use does not result in an unacceptable risk of serious adverse events.
What is the current status of trial NCT00925522?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2009-06. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00925522?
The interventions under investigation include: Therapy Cool Path Duo Cardiac Ablation System (DEVICE).
Who is sponsoring clinical trial NCT00925522?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.